Sequenom (NASDAQ: SQNM), Mettler-Toledo International Inc. (NYSE: MTD), Thermo Fisher (NYSE: TMO), Dendreon Co. (DNDN), People’s United Financial, Inc. (NASDAQ: PBCT) and Parkway Prop. (NYSE: PKY) ratings and price targets.
Mettler-Toledo International Inc. (MTD) is now covered by Cantor Fitzgerald. They have a “buy” rating on the company.
Sequenom (SQNM) is now covered by Dougherty & Co. They have a “Buy” rating on the company.
Thermo Fisher (TMO) is now covered by Cantor Fitzgerald. They have a “Buy” rating on the company.
Dendreon Co. (DNDN) had its “Sell” rating reiterated by Brean Murray Carret & Co.
People’s United Financial, Inc. (PBCT) had its “Neutral” rating reiterated by Zacks Investment Research. They have a price target of $14.00 on the company.
Parkway Prop. (PKY) had its “Neutral” rating reiterated by UBS AG (NYSE:UBS).
Showing posts with label Thermo Fisher Scientific. Show all posts
Showing posts with label Thermo Fisher Scientific. Show all posts
Friday, January 6, 2012
Wednesday, May 18, 2011
Price Targets on (STEC) (TGI) (TMO) (TRGL) (ZAGG) Updated
Analysts updated price targets on STEC Inc (NASDAQ: STEC), Triumph Group, Inc. (NYSE: TGI), Thermo Fisher Scientific (NYSE: TMO), Toreador Resources Co. (NASDAQ: TRGL) and ZAGG (NASDAQ: ZAGG).
Needham & Company cut their price target on STEC Inc (STEC) from $29.00 to $27.00. They have a “buy” rating on the company.
RBC Capital raised their price target on Triumph Group, Inc. (TGI) from $108.00 to $118.00. They have an “outperform” rating on the company.
Auriga raised their price target on Thermo Fisher Scientific (TMO) from $66.00 to $73.00. They have a “buy” rating on the company.
RBC Capital cut their price target on Toreador Resources Co. (TRGL) from $19.00 to $10.00. They have an “outperform” rating on the company.
Northland Securities raised their price target on ZAGG (ZAGG) from $12.50 to $14.50. They have an “outperform” rating on the company.
Needham & Company cut their price target on STEC Inc (STEC) from $29.00 to $27.00. They have a “buy” rating on the company.
RBC Capital raised their price target on Triumph Group, Inc. (TGI) from $108.00 to $118.00. They have an “outperform” rating on the company.
Auriga raised their price target on Thermo Fisher Scientific (TMO) from $66.00 to $73.00. They have a “buy” rating on the company.
RBC Capital cut their price target on Toreador Resources Co. (TRGL) from $19.00 to $10.00. They have an “outperform” rating on the company.
Northland Securities raised their price target on ZAGG (ZAGG) from $12.50 to $14.50. They have an “outperform” rating on the company.
Friday, April 29, 2011
Wyndham (WYN) (SRCL) (TDY) (TMO) (URBN) Price Targets Raised
Price targets on Wyndham Worldwide (NYSE: WYN), Teledyne Technologies Incorporated (NYSE: TDY), Thermo Fisher Scientific (NYSE: TMO), Urban Outfitters, Inc. (NASDAQ: URBN) and Stericycle Inc (NASDAQ: SRCL) raised by analysts.
Wunderlich raised their price target on Stericycle Inc (SRCL) to $85.00.
Jefferies (NYSE:JEF) raised their price target on Teledyne Technologies Incorporated (TDY) from $48.00 to $50.00. They have a “hold” rating on the company.
Jefferies raised their price target on Thermo Fisher Scientific (TMO) from $66.00 to $68.00.
RBC Capital raised their price target on Universal Health Services (UHS) from $52.00 to $60.00. They have an “outperform” rating on the company.
Needham & Company cut their price target on Urban Outfitters, Inc. (URBN) from $51.00 to $48.00. They have a “strong buy” rating on the company.
FBR Capital raised their price target on Wyndham Worldwide (NYSE: WYN) from $39.00 to $41.00. They have an “outperform” rating on the company.
Wunderlich raised their price target on Stericycle Inc (SRCL) to $85.00.
Jefferies (NYSE:JEF) raised their price target on Teledyne Technologies Incorporated (TDY) from $48.00 to $50.00. They have a “hold” rating on the company.
Jefferies raised their price target on Thermo Fisher Scientific (TMO) from $66.00 to $68.00.
RBC Capital raised their price target on Universal Health Services (UHS) from $52.00 to $60.00. They have an “outperform” rating on the company.
Needham & Company cut their price target on Urban Outfitters, Inc. (URBN) from $51.00 to $48.00. They have a “strong buy” rating on the company.
FBR Capital raised their price target on Wyndham Worldwide (NYSE: WYN) from $39.00 to $41.00. They have an “outperform” rating on the company.
Thursday, April 28, 2011
WellPoint (WLP) (TMO) (WU) (WYN) Get Ratings Reiterated by Analysts
WellPoint, Inc. (NYSE: WLP), Thermo Fisher Scient (NYSE: TMO), The Western Union Company (NYSE: WU) and Wyndham Worldwide (NYSE: WYN) get ratings reiterated by analysts.
Morgan Stanley reiterated an “Overweight” rating on Thermo Fisher Scient (TMO).
Deutsche Bank (NYSE:DB) reiterated a “Buy” rating on WellPoint, Inc. (WLP).
Morgan Stanley (NYSE:MS) reiterated an “Overweight” rating on The Western Union Company (WU).
Piper Jaffray reiterated an “Overweight” rating on The Western Union Company (WU). They have a price target of $26 on the firm.
JPMorgan Chase & Co. (NYSE:JPM) reiterated an “Overweight” rating on shares of Wyndham Worldwide (WYN).
Morgan Stanley reiterated an “Overweight” rating on Thermo Fisher Scient (TMO).
Deutsche Bank (NYSE:DB) reiterated a “Buy” rating on WellPoint, Inc. (WLP).
Morgan Stanley (NYSE:MS) reiterated an “Overweight” rating on The Western Union Company (WU).
Piper Jaffray reiterated an “Overweight” rating on The Western Union Company (WU). They have a price target of $26 on the firm.
JPMorgan Chase & Co. (NYSE:JPM) reiterated an “Overweight” rating on shares of Wyndham Worldwide (WYN).
Wednesday, December 15, 2010
Thermo Fisher (NYSE:TMO) Gets Some Love from Jefferies (NYSE:JEF)
Citing improving conditions in capital equipment markets and more stability in their cash flow streams, Jefferies (NYSE:JEF) is a little more bullish on Thermo Fisher Scientific (NYSE:TMO) than they have been.
Jefferies stated, "TMO's status as a highly-diversified, vertically-integrated life science and healthcare products franchise leverages it to rebounding conditions in capital equipment markets, while limiting the volatility of its cash flow stream. Recent capital re-deployment clarity should increase its appeal to a broader universe of investors, in our view."
EPS and revenue estimates for Thermo Fisher were maintained for Full year 2010,11,12, at $3.50/$10.8 billion, $3.90/$11.5 billion, and $4.15/$12.1 billion.
Jefferies maintains their "Buy" rating on Thermo Fisher Scientific, which closed Tuesday at $55.11, down $0.45, or 0.81 percent. They lowered their price target on them from $65 to $64.
Jefferies stated, "TMO's status as a highly-diversified, vertically-integrated life science and healthcare products franchise leverages it to rebounding conditions in capital equipment markets, while limiting the volatility of its cash flow stream. Recent capital re-deployment clarity should increase its appeal to a broader universe of investors, in our view."
EPS and revenue estimates for Thermo Fisher were maintained for Full year 2010,11,12, at $3.50/$10.8 billion, $3.90/$11.5 billion, and $4.15/$12.1 billion.
Jefferies maintains their "Buy" rating on Thermo Fisher Scientific, which closed Tuesday at $55.11, down $0.45, or 0.81 percent. They lowered their price target on them from $65 to $64.
Tuesday, December 14, 2010
Thermo Fisher (NYSE:TMO) Up on Dionex (Nasdaq:DNEX) Bid
Thermo Fisher Scientific (NYSE:TMO) pushed up Monday on news of their Dionex (Nasdaq:DNEX) bid..
Auriga said, "DNEX has expanded its presence in China and India, and that both regions remain a key source of growth. DNEX's customers in emerging markets are generally "green field" opportunities -- as they have limited installed base or legacy equipment in house. As such, customers are often more open (or able) to exploring new product platforms."
DNEX had sales of $420 million for full year 2010, with 30 percent coming from HPLC and 70 percent from IC.
EPS estimates from Auriga for Thermo Fisher for full year 2011 are kept in place at $4.15.
Thermo Fisher closed Monday at $55.56, up $2.52, or 4.75 percent. Auriga has a price target of $66 on them.
Auriga said, "DNEX has expanded its presence in China and India, and that both regions remain a key source of growth. DNEX's customers in emerging markets are generally "green field" opportunities -- as they have limited installed base or legacy equipment in house. As such, customers are often more open (or able) to exploring new product platforms."
DNEX had sales of $420 million for full year 2010, with 30 percent coming from HPLC and 70 percent from IC.
EPS estimates from Auriga for Thermo Fisher for full year 2011 are kept in place at $4.15.
Thermo Fisher closed Monday at $55.56, up $2.52, or 4.75 percent. Auriga has a price target of $66 on them.
Subscribe to:
Posts (Atom)